Sees Q3 adjusted EBITDA $77M-$81M. The company said, “Our consolidated financial statements for our three-month period ended September 27, 2025 are not yet available. Accordingly, the financial and operational results we present in this press release are preliminary estimates and subject to the completion of our financial closing procedures and any adjustments that may result from the completion of the quarterly review and finalization of our consolidated financial statements. As a result, these preliminary estimated results may differ from actual results that will be reflected in our consolidated financial statements for the fiscal quarter when they are completed and publicly disclosed. These preliminary estimated results may change and those changes may be material.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVAH:
- Aveanna announces offering of 10M shares of common stock for holders
- Aveanna price target raised to $9.50 from $6.50 at Truist
- Aveanna price target raised to $9 from $8 at UBS
- Aveanna Healthcare Highlights Transparency in Investor Presentation
- Aveanna Healthcare Refinances Credit Facility for Growth